Literature DB >> 8789897

Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome.

T Schmidt1, N Hackelsberger, R Widmer, C Meisel, A Pfeiffer, H Kaess.   

Abstract

BACKGROUND: Whether small-bowel motility is abnormal in the irritable bowel syndrome (IBS) is a controversy at present. The aim of our study was to compare ambulatory long-term jejunal motility in 35 IBS patients with predominant diarrhea to normal values obtained in 50 healthy controls.
METHODS: Twenty-four-hour motility was recorded in the proximal jejunum with a portable datalogger and tube-mounted miniature pressure sensors. Fasting motility in the waking (W) and sleeping (S) state and the motor response to a standardized evening meal of 600 kcal underwent visual and computer-aided analysis.
RESULTS: Fasting motility in patients showed migrating motor complex (MMC) cycles of normal length and composition. Uninterrupted runs of discrete clustered contractions during phase II (W) occurred in 57% of patients and 52% of controls but had a significantly longer duration in patients (33 +/- 5 versus 19 +/- 7 min; p < 0.005). During phase II (W) IBS patients had an increase in aborally propagated contractions (41 +/- 2% versus 35 +/- 2%; p < 0.01) and higher contraction amplitudes (26.3 +/- 0.8 versus 23.0 +/- 0.5 mm Hg; p < 0.01). Similar differences were obtained during postprandial motility (47 +/- 3% versus 39 +/- 3%; p < 0.01, and 25.9 +/- 0.9 versus 23.8 +/- 0.05 mm Hg; p < 0.02). In three patients (8.6%) disturbed aboral migration of phase III and irregular burst activity, manometric features of chronic idiopathic intestinal pseudo-obstruction, were identified. Whereas 57% of patients had an entirely normal 24-h manometry, 43% had at least one finding not present in any healthy control.
CONCLUSION: Small-intestinal motility is frequently but not universally abnormal in diarrhea-predominant IBS. The abnormal manometric findings are heterogeneous and range from subtle quantitative changes to severe qualitative abnormalities resembling chronic idiopathic intestinal pseudo-obstruction in a small subset of patients.

Entities:  

Mesh:

Year:  1996        PMID: 8789897     DOI: 10.3109/00365529609009131

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

Review 1.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.

Authors:  B Dave; W Rubin
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

Review 4.  Irritable bowel syndrome: a clinical review.

Authors:  Rosa L S Soares
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)].

Authors:  M Simrén; M Castedal; J Svedlund; H Abrahamsson; E Björnsson
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

6.  Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms.

Authors:  Olafur S Palsson; Marsha J Turner; David A Johnson; Charles K Burnett; William E Whitehead
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

7.  Effect of ethanol on postprandial duodenojejunal motility in humans.

Authors:  T Schmidt; R Eberle; A Pfeiffer; H Kaess
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

Review 8.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 9.  Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity.

Authors:  Elena F Verdu; David Armstrong; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2009-06       Impact factor: 10.864

Review 10.  Use of rifaximin in gastrointestinal and liver diseases.

Authors:  Rani H Shayto; Rachel Abou Mrad; Ala I Sharara
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.